BRCA2 and neoplasm: The differing results seen between our mouse model and the K14Cre Brca2/Tp53-mutant mouse model may be due to the differences in cell-of-origin of the tumours, resulting in variances in tumour phenotypes, as we have shown in a previous publication [15].